Your Health Plan:
SUSVIMO (ranibizumab) is a biologic prescription drug for treatment of Age related macular degeneration. SUSVIMO is a vascular endothelial growth factor inhibitor. It is available in the form of intravitreal injection.
See full Prescribing Information for important safety information and clinical studies.
SUSVIMO is not covered by . Cash price for 30-day supply is $9300-11100.
Patient Assistance Prorgams and Coupons are found: